EGFR and non-small cell lung carcinoma: Clinical trial NCT01193829 (Development of Circulating Tumor Cell Molecular Diagnostics Using a Novel Microfluidic Device) aimed at comparing EGFR mutations in primary NSCLC tumors of respective CTCs isolated via a label-free microfluidic device.